Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

Please Try Again

Password Hint : {{passwordHint}}

Remember me

Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > BTD Approval Request...???

<< Previous

Bullboard Posts

Next >>

Comment by Yajneon Apr 11, 2022 2:26pm

152 Views

Post# 34594465

RE:RE:RE:RE:RE:RE:RE:RE:BTD Approval Request...???

Reporting deadline is May 2 this year for venture Co's with Dec31 YE. Normally April 30, but since it falls on weekend, the date is May2

enriquesuave wrote:
Anyone know when Q4 end of year 2021 financials come out? If I remember usually end of April and Q1 is end of May. I believe they told someone who called last November that they would release Quarterly at same time as financials. Next few weeks/months will hopefully have some nice developments and may we see BTD and our SP hit its $1.20 SP target.

ScienceFirst wrote:

Yep! That would be wise. And that's fair to assume that this is what they're gonna do.

For example, better to wait for the proper time (e.g. Breakthrough designation) to give more details about Rutherrin than too early as a Breakthrough designation would give us huge visibility.

You have to be strategic sometimes.

_________________

Rumpl3StiltSkin - (4/11/2022 1:47:59 PM)

RE:RE:RE:RE:RE:BTD Approval Request...???

Fred, I can only hope they are holding those juicy PRs for after BTD approval, for Max impact...